Carregant...
Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration
PURPOSE: There is no prevention or treatment for diabetic retinal neurodegeneration (DRN), which is a complication of diabetes that can occur independently of diabetic retinopathy (DR). We hypothesized that an intravitreal fluocinolone acetonide (FAc) implant may affect the rate of DRN when used in...
Guardat en:
| Publicat a: | Invest Ophthalmol Vis Sci |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Association for Research in Vision and Ophthalmology
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6528841/ https://ncbi.nlm.nih.gov/pubmed/31100106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.18-24643 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|